Work

MA11.12 A Phase Ib Study of TQB2618 (Anti-TIM-3) in Combination with Penpulimab and Chemotherapy in Patients with Non-Small Cell Lung Cancer

Year: 2024

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.182

Authors: L. Wu, G. Lin, B. Li, Y. Fang, Y. Wang, S. Cang, X. Li, X. Li, R. Wang, Q. Chu, Q. Yu, R. Ning, Z. Gui, Z. Zhou

Institutions: Hunan Cancer Hospital, Fujian Provincial Cancer Hospital, Affiliated Hospital of Guilin Medical College, Sir Run Run Shaw Hospital, Zhejiang University, West China Hospital of Sichuan University, Henan Provincial People's Hospital, Affiliated Zhongshan Hospital of Dalian University, First Affiliated Hospital of Zhengzhou University, Tongji Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403420123

Cites:

Cited by: 1

Related to: 10